Estefanía García‐Guerrero

Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab

Estefanía García‐Guerrero, Ralph Götz, Sören Doose et al. · Leukemia · 2020 · 74 citations · Full text

Medicine, Oncology, Pharmacology +16

Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies

Clara García-Calderón, Belén Sierro-Martínez, Estefanía García‐Guerrero et al. · Frontiers in Immunology · 2023 · 43 citations · Full text

Medicine, Hematology, Immunology +17

Cannabinoid derivatives exert a potent anti-myeloma activity both<i>in vitro</i>and<i>in vivo</i>

María Victoria Barbado, Mayte Medrano, Teresa Caballero‐Velázquez et al. · International Journal of Cancer · 2016 · 36 citations · Full text

Medicine, Oncology, Pharmacology +17

Human acute myeloid leukemia cells express Neurokinin-1 receptor, which is involved in the antileukemic effect of Neurokinin-1 receptor antagonists

Águeda Molinos-Quintana, P. Trujillo-Hacha, José I. Piruat et al. · Investigational New Drugs · 2018 · 34 citations

Medicine, Oncology, Pharmacology +8

All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells

Estefanía García‐Guerrero, Luis Gerardo Rodríguez‐Lobato, Belén Sierro-Martínez et al. · Haematologica · 2022 · 31 citations · Full text

Medicine, Cell Biology, Pharmacology +15